rs11135910
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_022659.4(EBF2):c.483-1473G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.134 in 152,238 control chromosomes in the GnomAD database, including 1,492 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.13 ( 1492 hom., cov: 33)
Consequence
EBF2
NM_022659.4 intron
NM_022659.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.00600
Publications
52 publications found
Genes affected
EBF2 (HGNC:19090): (EBF transcription factor 2) The protein encoded by this gene belongs to the COE (Collier/Olf/EBF) family of non-basic, helix-loop-helix transcription factors that have a well conserved DNA binding domain. The COE family proteins play an important role in variety of developmental processes. Studies in mouse suggest that this gene may be involved in the differentiation of osteoblasts. [provided by RefSeq, Oct 2011]
EBF2 Gene-Disease associations (from GenCC):
- endocrine system disorderInheritance: AD Classification: LIMITED Submitted by: Broad Center for Mendelian Genomics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.157 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| EBF2 | ENST00000520164.6 | c.483-1473G>A | intron_variant | Intron 5 of 15 | 2 | NM_022659.4 | ENSP00000430241.1 | |||
| EBF2 | ENST00000517825.1 | n.802-1473G>A | intron_variant | Intron 5 of 5 | 1 | |||||
| EBF2 | ENST00000408929.7 | c.39-1473G>A | intron_variant | Intron 4 of 14 | 2 | ENSP00000386178.3 |
Frequencies
GnomAD3 genomes AF: 0.134 AC: 20364AN: 152120Hom.: 1487 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
20364
AN:
152120
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.134 AC: 20387AN: 152238Hom.: 1492 Cov.: 33 AF XY: 0.130 AC XY: 9672AN XY: 74440 show subpopulations
GnomAD4 genome
AF:
AC:
20387
AN:
152238
Hom.:
Cov.:
33
AF XY:
AC XY:
9672
AN XY:
74440
show subpopulations
African (AFR)
AF:
AC:
4199
AN:
41528
American (AMR)
AF:
AC:
2440
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
597
AN:
3472
East Asian (EAS)
AF:
AC:
158
AN:
5188
South Asian (SAS)
AF:
AC:
716
AN:
4816
European-Finnish (FIN)
AF:
AC:
1005
AN:
10600
Middle Eastern (MID)
AF:
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10857
AN:
68016
Other (OTH)
AF:
AC:
284
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
907
1814
2722
3629
4536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
459
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.